2004 年至 2015 年欧洲按虚弱状态划分的健康预期寿命：SHARE 的研究结果。
Healthy life expectancy by frailty state in Europe from 2004 to 2015: findings from SHARE.
机构信息
Unit of Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Interdisiciplinary Center on Population Dynamics, University of Southern Denmark, Odense, Denmark.
出版信息
Eur J Public Health. 2021 Jul 13;31(3):554-560. doi: 10.1093/eurpub/ckab012.
BACKGROUND
As populations age, the possible consequences of increased frailty are a major concern for the health sector. Here, we investigate how life expectancy with and without frailty has changed during a 10-11-year-period across Europe.
METHODS
The Sullivan method was used to investigate changes in life expectancy with and without frailty in 10 European countries. Frailty status (non-frail, pre-frail and frail) was determined by use of the Survey of Health, Ageing and Retirement in Europe Frailty Instrument (SHARE-FI). Data on frailty prevalence was obtained from 21 698 individuals in wave 1 (2004-05) and 38 859 individuals in wave 6 (2015) of the SHARE. Information on mortality was obtained from the Eurostat Database.
RESULTS
In 2015, women aged 70 spent 25.0% (95% CI: 24.0-26.1) of their remaining life expectancy in a frail state, and the number for men was 11.5% (95% CI: 10.7-12.3). Southern Europeans spent 24.2% (95% CI: 22.9-25.4) of their remaining life expectancy in a frail state and the numbers for Central Europeans and Northern Europeans were 17.0% (95% CI: 16.0-17.9) and 12.2% (95% CI: 10.9-13.5), respectively. From 2004-05 to 2015, life expectancy increased by 1.1 years (from 15.3 to 16.4 years) for 70-year-old Europeans. Similarly, non-frail life expectancy increased by 1.1 years (95% CI: 0.8-1.4), whereas no significant changes in life expectancy in frail states were observed.
CONCLUSIONS
This study suggests that Europeans today spend more years in a non-frail state than Europeans did 10-11 years ago. Our findings reflect a considerable inequality by gender and region.
背景
随着人口老龄化，衰弱带来的潜在后果成为卫生部门的主要关注点。在此，我们研究了在 10-11 年期间，欧洲各国衰弱患者和非衰弱患者的预期寿命分别发生了怎样的变化。
方法
我们使用 Sullivan 法调查了 10 个欧洲国家衰弱患者和非衰弱患者的预期寿命变化。使用欧洲健康、老龄化和退休调查衰弱量表（SHARE-FI）来确定衰弱状况（非衰弱、衰弱前期和衰弱）。第 1 波（2004-05 年）和第 6 波（2015 年）的 SHARE 中，共有 21698 名个体的衰弱前期患病率数据，38859 名个体的衰弱患病率数据。死亡率信息来自于 Eurostat 数据库。
结果
2015 年，70 岁女性在衰弱状态下度过其剩余预期寿命的 25.0%（95%CI：24.0-26.1），男性这一比例为 11.5%（95%CI：10.7-12.3）。南部欧洲人在衰弱状态下度过其剩余预期寿命的 24.2%（95%CI：22.9-25.4），中部欧洲人和北部欧洲人这一比例分别为 17.0%（95%CI：16.0-17.9）和 12.2%（95%CI：10.9-13.5）。从 2004-05 年到 2015 年，70 岁欧洲人的预期寿命增加了 1.1 年（从 15.3 年增加到 16.4 年）。同样，非衰弱患者的预期寿命增加了 1.1 年（95%CI：0.8-1.4），而衰弱状态下的预期寿命没有显著变化。
结论
本研究表明，与 10-11 年前相比，现在的欧洲人在非衰弱状态下度过的时间更多。我们的研究结果反映了按性别和地区划分的相当大的不平等。
Zotero 插件